Nurse Practitioner in Pamplico, SC Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Lindsey Rebecca Weaver, APRN Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 730 W Highway 378 Hannah, Pamplico, SC 29583 Phone: 843-601-0128 |
Sandra Weatherford, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 953 South Pamplico Hwy, Pamplico, SC 29583 Phone: 843-493-5252 Fax: 843-493-2372 |
News Archive
Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles
The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.
Study: Primary care density correlated with lung cancer mortality in white population
Lung cancer remains the leading cause of cancer-related deaths and is tied as the third leading cause of death overall in industrialized countries. Within the United States, several groups identified by race, sex, and socioeconomic status have been linked to increased cancer mortality, suggesting a disparity because of these characteristics.
ADMA Biologics reports consolidated net loss of $15.5M in 2013
ADMA Biologics, Inc., a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced its financial results for the year ended December 31, 2013 and provided recent company developments as well as anticipated milestones for 2014.
RPB honors Mass. Eye and Ear ophthalmologist with Senior Scientific Investigator Award
Reza Dana, M.D., M.P.H., M.Sc. of Mass. Eye and Ear/Harvard Medical School, was awarded the Research to Prevent Blindness (RPB) Senior Scientific Investigator Award in the amount of $150,000 to support research into the causes, treatment and prevention of blinding diseases.
FDA categorizes Nanosphere's RVNATSP assay on Verigene SP System as "Moderate Complexity"
Nanosphere, Inc., a leader in the development and commercialization of advanced molecular diagnostics systems, received notification from the U.S. Food and Drug Administration (FDA) that its respiratory virus panel (RVNATSP) performed on the Verigene SP System has been categorized as "Moderate Complexity" under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).
› Verified 6 days ago